SIRPA and cancer: In many cancers, the overexpression of “don’t eat me” signals—such as those mediated by the CD47–SIRPα pathway—counteracts the pro-phagocytic signal of CRT, thereby preventing phagocytosis and hindering subsequent antigen uptake, ultimately disrupting the cancer–immunity cycle [40].